Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LifeMD, Inc. Director's Dealing 2021

Apr 23, 2021

33298_dirs_2021-04-22_90cd35c0-22ba-4b0a-b056-570adfe0fe2e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LifeMD, Inc. (LFMD)
CIK: 0000948320
Period of Report: 2021-04-18

Reporting Person: Strawn John R Jr (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-04-18 Common Stock, par value $0.01 M 200000 $1 Acquired 203467 Direct
2021-04-18 Common Stock, par value $0.01 F 20060 $9.97 Disposed 183407 Direct
2021-04-18 Common Stock, par value $0.01 M 100000 $2 Acquired 283407 Direct
2021-04-18 Common Stock, par value $0.01 F 20060 $9.97 Disposed 263347 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-04-18 Option $1 M 200000 Disposed 2021-04-20 Common Stock, par value $0.01 (200000) Direct
2021-04-18 Option $2 M 100000 Disposed 2021-04-20 Common Stock, par value $0.01 (100000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock, par value $0.01 60000 Indirect

Footnotes

F1: The Amount of Securities Beneficially Owned reflects a correction of an additional 467 shares from previous Form 3/A filing of the reporting person.

F2: Reflects 20,060 shares withheld by issuer to fund the cashless exercise of 200,000 options pursuant to the Reporting Person's Stock Option Agreement.

F3: Reflects 20,060 shares withheld by issuer to fund the cashless exercise of 100,000 options pursuant to the Reporting Person's Stock Option Agreement.

F4: Mr. Strawn has shared voting and dispositive power and as partner of Strawn Pickens LLP he shares a pecuniary interest. The shares were subject to a 1-for-5 reverse stock split in October, 2020.

F5: The original grant of 1,000,000 common stock options was subject to a 1-for-5 reverse stock split in October, 2020. The exercise reported herein is the shares remaining after the split.

F6: The original grant of 500,000 common stock options was subject to a 1-for-5 reverse stock split in October, 2020. The exercise reported herein is the shares remaining after the split.